When we examined NOS2 expression in 3 breast cancer patient groups (all subtypes, basal-like, and ER−/PR−) we found that high NOS2 expression was associated with decreased overall survival (confirming previous reports11) (Fig. 4A). The gene discussed is NOS2; the disease is breast cancer.